The North America Virology Specimen Collection Market would witness market growth of 0.02% CAGR during the forecast period (2021-2027).
The global incidence of bacterial and viral diseases is on the rise. Climate change and the lowered immunity of a population, that is more protected from acquiring natural immunity can be responsible for this scenario. Globalization exacerbates the situation, as microbes which are native to one place mix with humans in other parts of the world.
To avoid contamination from ambient microorganisms, the assembling of Specimen is done with extreme caution and in a sterile atmosphere. To maintain hygiene standards, the equipment utilized must be of excellent quality. Following the COVID-19 outbreak, an inclusive mandate for sample testing was triggered, allowing developed and developing countries to contribute equally to global health bodies like the WHO (World Health Organization).
Under a USD 6.0 million contract with Inflammatix Inc., the US HHS supported the development of host-response testing technology as of November 2019. The company is working on three diagnostic tests that will determine if an illness is bacterial or viral in a matter of minutes. This enables clinicians to make informed, early treatment decisions. Such initiatives are also at the heart of the corporations' plan to increase the number of early diagnoses.
The US market dominated the North America Virology Specimen Collection Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $1,516.2 million by 2027. The Canada market is expected to witness a CAGR of 2.3% during (2021 - 2027). Additionally, The Mexico market would showcase a CAGR of 1.4% during (2021 - 2027).
Based on Sample, the market is segmented into Nasopharyngeal Samples, Throat Samples, Cervical Samples, Nasal Samples, Blood Samples, Oral Samples, and Others. Based on Product Type, the market is segmented into Viral Transport Media, Specimen Collection Tubes, Blood Collection Kits and Swabs. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Virology Specimen Collection Market is Estimated to reach $5.6 Billion by 2027, at a CAGR of 0.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Trinity Biotech Plc, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, DiaSorin S.p.A., Vircell S.L., Quidel Corporation, Titan Biotech Ltd., Puritan Medical Products, Copan Italia s.p.a., and Hardy Diagnostics.
By Sample
By Product Type
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
